Fund profile
Tickers
LABU
Fund manager
Total assets
$1.45 bn
Liabilities
$357.53 mm
Net assets
$1.09 bn
Number of holdings
151.00
LABU stock data
151 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
DREYFUS GOV'T CASH MGMT -INSTITUTIONAL CUSIP 262006208 DGCXX (#289) | 290.01 mm | 290.01 mm principal | 26.55 | Short-term investment vehicle | Long | USA |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
BNP Paribas
|
77.59 mm | 1.00 contracts | 7.10 | Equity derivative | N/A | USA |
GOLDMAN FINL SQ TRSRY INST 506 | 77.32 mm | 77.32 mm principal | 7.08 | Short-term investment vehicle | Long | USA |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
Goldman Sachs & Co. LLC
|
56.78 mm | 1.00 contracts | 5.20 | Equity derivative | N/A | USA |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
Citibank National Association
|
55.27 mm | 1.00 contracts | 5.06 | Equity derivative | N/A | USA |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
Bank of America N.A. (formerly Merrill Lynch)
|
52.29 mm | 1.00 contracts | 4.79 | Equity derivative | N/A | USA |
DREYFUS TRSRY SECURITIES CASH MGMT | 42.94 mm | 42.94 mm principal | 3.93 | Short-term investment vehicle | Long | USA |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
UBS AG
|
31.35 mm | 1.00 contracts | 2.87 | Equity derivative | N/A | USA |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
Barclays Bank PLC
|
26.49 mm | 1.00 contracts | 2.42 | Equity derivative | N/A | USA |
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
J.P. MORGAN SECURITIES LLC.
|
23.95 mm | 1.00 contracts | 2.19 | Equity derivative | N/A | USA |
GILD Gilead Sciences, Inc. | 20.25 mm | 266.21 k shares | 1.85 | Common equity | Long | USA |
AMGN Amgen Inc. | 19.28 mm | 58.00 k shares | 1.77 | Common equity | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 19.17 mm | 134.79 k shares | 1.75 | Common equity | Long | USA |
ABBV AbbVie Inc. | 19.04 mm | 102.74 k shares | 1.74 | Common equity | Long | USA |
EXAS Exact Sciences Corporation | 18.89 mm | 413.54 k shares | 1.73 | Common equity | Long | USA |
UTHR United Therapeutics Corporation | 18.83 mm | 60.12 k shares | 1.72 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 18.04 mm | 16.72 k shares | 1.65 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 18.00 mm | 75.79 k shares | 1.65 | Common equity | Long | USA |
VKTX Viking Therapeutics, Inc. | 17.87 mm | 313.55 k shares | 1.64 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 17.86 mm | 36.02 k shares | 1.63 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 17.49 mm | 207.40 k shares | 1.60 | Common equity | Long | USA |
INCY Incyte Corporation | 17.19 mm | 264.25 k shares | 1.57 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 15.94 mm | 112.62 k shares | 1.46 | Common equity | Long | USA |
BIIB Biogen Inc. | 15.94 mm | 74.75 k shares | 1.46 | Common equity | Long | USA |
NTRA Natera, Inc. | 15.72 mm | 153.51 k shares | 1.44 | Common equity | Long | USA |
MRNA Moderna, Inc. | 14.75 mm | 123.68 k shares | 1.35 | Common equity | Long | USA |
CYTK Cytokinetics, Incorporated | 14.46 mm | 245.04 k shares | 1.32 | Common equity | Long | USA |
CRSP CRISPR Therapeutics AG | 9.77 mm | 170.57 k shares | 0.89 | Common equity | Long | Switzerland |
MDGL Madrigal Pharmaceuticals, Inc. | 9.69 mm | 34.03 k shares | 0.89 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 9.61 mm | 88.73 k shares | 0.88 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals, Inc. | 8.95 mm | 226.10 k shares | 0.82 | Common equity | Long | USA |
ROIV Roivant Sciences Ltd. | 8.41 mm | 775.12 k shares | 0.77 | Common equity | Long | Bermuda |
KRYS Krystal Biotech, Inc. | 8.14 mm | 39.05 k shares | 0.75 | Common equity | Long | USA |
RVMD Revolution Medicines, Inc. | 7.92 mm | 173.47 k shares | 0.72 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 7.80 mm | 157.77 k shares | 0.71 | Common equity | Long | USA |
CERE Cerevel Therapeutics Holdings Inc | 7.70 mm | 171.26 k shares | 0.70 | Common equity | Long | USA |
EXEL Exelixis, Inc. | 7.65 mm | 326.42 k shares | 0.70 | Common equity | Long | USA |
INSM Insmed Incorporated | 7.63 mm | 104.85 k shares | 0.70 | Common equity | Long | USA |
ALKS Alkermes plc | 7.36 mm | 269.54 k shares | 0.67 | Common equity | Long | Ireland |
BHVN Biohaven Ltd. | 7.19 mm | 182.82 k shares | 0.66 | Common equity | Long | Virgin Islands (British) |
PCVX Vaxcyte, Inc. | 6.98 mm | 88.47 k shares | 0.64 | Common equity | Long | USA |
HALO Halozyme Therapeutics, Inc. | 6.76 mm | 122.37 k shares | 0.62 | Common equity | Long | USA |
BBIO BridgeBio Pharma, Inc. | 6.59 mm | 253.79 k shares | 0.60 | Common equity | Long | USA |
TGTX TG Therapeutics, Inc. | 6.22 mm | 314.85 k shares | 0.57 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 5.83 mm | 135.83 k shares | 0.53 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 5.57 mm | 104.80 k shares | 0.51 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics, Inc. | 5.49 mm | 629.44 k shares | 0.50 | Common equity | Long | USA |
ACAD ACADIA Pharmaceuticals Inc. | 5.42 mm | 285.06 k shares | 0.50 | Common equity | Long | USA |
TWST Twist Bioscience Corporation | 5.38 mm | 96.32 k shares | 0.49 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 5.31 mm | 117.87 k shares | 0.49 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics, Inc. | 5.23 mm | 145.65 k shares | 0.48 | Common equity | Long | USA |
NTLA Intellia Therapeutics, Inc. | 5.11 mm | 194.86 k shares | 0.47 | Common equity | Long | USA |
ACLX Arcellx, Inc. | 4.96 mm | 80.18 k shares | 0.45 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 4.89 mm | 154.41 k shares | 0.45 | Common equity | Long | USA |
IDYA IDEAYA Biosciences, Inc. | 4.83 mm | 112.28 k shares | 0.44 | Common equity | Long | USA |
NUVL Nuvalent, Inc. | 4.83 mm | 60.45 k shares | 0.44 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 4.66 mm | 102.15 k shares | 0.43 | Common equity | Long | USA |
FOLD Amicus Therapeutics, Inc. | 4.40 mm | 426.70 k shares | 0.40 | Common equity | Long | USA |
GERN Geron Corporation | 4.28 mm | 903.95 k shares | 0.39 | Common equity | Long | USA |
CLDX Celldex Therapeutics, Inc. | 4.25 mm | 111.65 k shares | 0.39 | Common equity | Long | USA |
VERA Vera Therapeutics, Inc. | 4.16 mm | 113.77 k shares | 0.38 | Common equity | Long | USA |
MORF Morphic Holding, Inc. | 3.95 mm | 69.67 k shares | 0.36 | Common equity | Long | USA |
KYMR Kymera Therapeutics, Inc. | 3.92 mm | 84.86 k shares | 0.36 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals, Inc. | 3.91 mm | 136.92 k shares | 0.36 | Common equity | Long | USA |
IMVT Immunovant, Inc. | 3.82 mm | 131.47 k shares | 0.35 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals, Inc. | 3.77 mm | 166.25 k shares | 0.35 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc. | 3.45 mm | 141.53 k shares | 0.32 | Common equity | Long | USA |
APGE Apogee Therapeutics, Inc. | 3.41 mm | 69.93 k shares | 0.31 | Common equity | Long | USA |
ARDX Ardelyx, Inc. | 3.33 mm | 600.54 k shares | 0.31 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals, Inc. | 3.33 mm | 71.82 k shares | 0.31 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals, Inc. | 3.27 mm | 67.80 k shares | 0.30 | Common equity | Long | USA |
DVAX Dynavax Technologies Corporation | 3.26 mm | 291.24 k shares | 0.30 | Common equity | Long | USA |
ADMA ADMA Biologics, Inc. | 3.21 mm | 261.51 k shares | 0.29 | Common equity | Long | USA |
PTCT PTC Therapeutics, Inc. | 3.18 mm | 93.87 k shares | 0.29 | Common equity | Long | USA |
BCRX BioCryst Pharmaceuticals, Inc. | 3.17 mm | 435.17 k shares | 0.29 | Common equity | Long | USA |
NVAX Novavax, Inc. | 3.13 mm | 244.68 k shares | 0.29 | Common equity | Long | USA |
VCEL Vericel Corporation | 3.12 mm | 61.77 k shares | 0.29 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals, Inc. | 3.05 mm | 371.78 k shares | 0.28 | Common equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 3.02 mm | 113.07 k shares | 0.28 | Common equity | Long | USA |
CPRX Catalyst Pharmaceuticals, Inc. | 2.99 mm | 173.33 k shares | 0.27 | Common equity | Long | USA |
JANX Janux Therapeutics, Inc. | 2.93 mm | 72.18 k shares | 0.27 | Common equity | Long | USA |
NRIX Nurix Therapeutics, Inc. | 2.81 mm | 128.30 k shares | 0.26 | Common equity | Long | USA |
KROS Keros Therapeutics, Inc. | 2.70 mm | 53.76 k shares | 0.25 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 2.66 mm | 109.93 k shares | 0.24 | Common equity | Long | USA |
PTGX Protagonist Therapeutics, Inc. | 2.63 mm | 70.34 k shares | 0.24 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals, Inc. | 2.61 mm | 64.34 k shares | 0.24 | Common equity | Long | USA |
VCYT Veracyte, Inc. | 2.47 mm | 102.87 k shares | 0.23 | Common equity | Long | USA |
IRWD Ironwood Pharmaceuticals, Inc. | 2.45 mm | 359.13 k shares | 0.22 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 2.44 mm | 87.32 k shares | 0.22 | Common equity | Long | USA |
ARQT Arcutis Biotherapeutics, Inc. | 2.44 mm | 242.45 k shares | 0.22 | Common equity | Long | USA |
SLNO Soleno Therapeutics, Inc. | 2.43 mm | 50.40 k shares | 0.22 | Common equity | Long | USA |
KURA Kura Oncology, Inc. | 2.42 mm | 116.41 k shares | 0.22 | Common equity | Long | USA |
VRDN Viridian Therapeutics, Inc. | 2.28 mm | 135.46 k shares | 0.21 | Common equity | Long | USA |
PRAX Praxis Precision Medicines, Inc. | 2.23 mm | 38.65 k shares | 0.20 | Common equity | Long | USA |
PRTA Prothena Corporation plc | 2.11 mm | 90.65 k shares | 0.19 | Common equity | Long | Ireland |
IBRX ImmunityBio, Inc. | 2.10 mm | 407.07 k shares | 0.19 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals, Inc. | 2.00 mm | 139.83 k shares | 0.18 | Common equity | Long | USA |
SANA Sana Biotechnology, Inc. | 1.94 mm | 318.08 k shares | 0.18 | Common equity | Long | USA |
CGEM Cullinan Oncology, Inc. | 1.89 mm | 97.79 k shares | 0.17 | Common equity | Long | USA |
MNKD MannKind Corporation | 1.89 mm | 327.37 k shares | 0.17 | Common equity | Long | USA |
XNCR Xencor, Inc. | 1.82 mm | 89.23 k shares | 0.17 | Common equity | Long | USA |
CDMO Avid Bioservices, Inc. | 1.80 mm | 172.20 k shares | 0.16 | Common equity | Long | USA |
SYRE Spyre Therapeutics, Inc. | 1.72 mm | 62.71 k shares | 0.16 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 1.71 mm | 72.90 k shares | 0.16 | Common equity | Long | USA |
SMMT Summit Therapeutics Inc. | 1.67 mm | 155.01 k shares | 0.15 | Common equity | Long | USA |
IMNM Immunome, Inc. | 1.67 mm | 108.43 k shares | 0.15 | Common equity | Long | USA |
CDNA CareDx, Inc | 1.67 mm | 83.57 k shares | 0.15 | Common equity | Long | USA |
TVTX Travere Therapeutics, Inc. | 1.62 mm | 170.33 k shares | 0.15 | Common equity | Long | USA |
COGT Cogent Biosciences, Inc. | 1.62 mm | 171.89 k shares | 0.15 | Common equity | Long | USA |
ANAB AnaptysBio, Inc. | 1.62 mm | 46.42 k shares | 0.15 | Common equity | Long | USA |
CGON CG Oncology, Inc. Common stock | 1.59 mm | 47.61 k shares | 0.15 | Common equity | Long | USA |
FDMT 4D Molecular Therapeutics, Inc. | 1.58 mm | 89.30 k shares | 0.14 | Common equity | Long | USA |
OLMA Olema Pharmaceuticals, Inc. | 1.54 mm | 95.32 k shares | 0.14 | Common equity | Long | USA |
KNSA Kiniksa Pharmaceuticals, Ltd. | 1.51 mm | 56.64 k shares | 0.14 | Common equity | Long | UK |
RLAY Relay Therapeutics, Inc. | 1.49 mm | 181.20 k shares | 0.14 | Common equity | Long | USA |
RCUS Arcus Biosciences, Inc. | 1.47 mm | 89.51 k shares | 0.13 | Common equity | Long | USA |
AVXL Anavex Life Sciences Corp. | 1.42 mm | 209.59 k shares | 0.13 | Common equity | Long | USA |
VIR Vir Biotechnology, Inc. | 1.38 mm | 136.28 k shares | 0.13 | Common equity | Long | USA |
RGNX REGENXBIO Inc. | 1.37 mm | 96.42 k shares | 0.13 | Common equity | Long | USA |
ALT Altimmune, Inc. | 1.32 mm | 207.05 k shares | 0.12 | Common equity | Long | USA |
CRBP Corbus Pharmaceuticals Holdings, Inc. | 1.29 mm | 21.69 k shares | 0.12 | Common equity | Long | USA |
SAGE Sage Therapeutics, Inc. | 1.26 mm | 115.17 k shares | 0.12 | Common equity | Long | USA |
FATE Fate Therapeutics, Inc. | 1.25 mm | 234.34 k shares | 0.11 | Common equity | Long | USA |
ETNB 89bio, Inc. | 1.23 mm | 134.11 k shares | 0.11 | Common equity | Long | USA |
ORIC ORIC Pharmaceuticals, Inc. | 1.22 mm | 108.59 k shares | 0.11 | Common equity | Long | USA |
ATXS Astria Therapeutics, Inc. | 1.20 mm | 102.62 k shares | 0.11 | Common equity | Long | USA |
CCCC C4 Therapeutics, Inc. | 1.16 mm | 173.56 k shares | 0.11 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 1.15 mm | 389.76 k shares | 0.10 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corporation | 1.13 mm | 124.26 k shares | 0.10 | Common equity | Long | USA |
STOK Stoke Therapeutics, Inc. | 1.12 mm | 74.65 k shares | 0.10 | Common equity | Long | USA |
EDIT Editas Medicine, Inc. | 1.09 mm | 200.79 k shares | 0.10 | Common equity | Long | USA |
OCGN Ocugen, Inc. | 1.05 mm | 744.84 k shares | 0.10 | Common equity | Long | USA |
SCLX Scilex Holding Company | 986.01 k | 620.13 k shares | 0.09 | Common equity | Long | USA |
VERV Verve Therapeutics, Inc. | 976.04 k | 139.43 k shares | 0.09 | Common equity | Long | USA |
IRON Disc Medicine, Inc. | 967.04 k | 22.41 k shares | 0.09 | Common equity | Long | USA |
MDXG MiMedx Group, Inc. | 961.75 k | 129.09 k shares | 0.09 | Common equity | Long | USA |
HUMA Humacyte, Inc. | 921.91 k | 97.45 k shares | 0.08 | Common equity | Long | USA |
SPRY ARS Pharmaceuticals, Inc. | 866.56 k | 79.72 k shares | 0.08 | Common equity | Long | USA |
VYGR Voyager Therapeutics, Inc. | 766.37 k | 83.39 k shares | 0.07 | Common equity | Long | USA |
HRTX Heron Therapeutics, Inc. | 714.73 k | 240.65 k shares | 0.07 | Common equity | Long | USA |
CABA Cabaletta Bio, Inc. | 687.22 k | 96.79 k shares | 0.06 | Common equity | Long | USA |
TNGX Tango Therapeutics, Inc. | 670.80 k | 68.10 k shares | 0.06 | Common equity | Long | USA |
CRGX CARGO Therapeutics, Inc. Common Stock | 643.67 k | 37.80 k shares | 0.06 | Common equity | Long | USA |
ZNTL Zentalis Pharmaceuticals, Inc. | 609.07 k | 156.57 k shares | 0.06 | Common equity | Long | USA |
ITOS iTeos Therapeutics, Inc. | 591.34 k | 33.62 k shares | 0.05 | Common equity | Long | USA |
SVRA Savara Inc. | 582.98 k | 126.74 k shares | 0.05 | Common equity | Long | USA |
ALEC Alector, Inc. | 564.17 k | 94.03 k shares | 0.05 | Common equity | Long | USA |
INHIBRX INC CVR
|
0 | 164.17 k shares | 0.00 | Common equity | Long | USA |
OABI OmniAb, Inc. | 0 | 14.78 k shares | 0.00 | Common equity | Long | USA |
OABI OmniAb, Inc. | 0 | 14.78 k shares | 0.00 | Common equity | Long | USA |
GOLDMAN SACHS FIN GOV 465 INSTITUT | 0 | 0.00 principal | 0.00 | Short-term investment vehicle | Long | USA |